Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Gross Margin (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Gross Margin for 13 consecutive years, with 53.22% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 10.0% to 53.22% in Q4 2025 year-over-year; TTM through Dec 2025 was 53.48%, a 42.0% increase, with the full-year FY2025 number at 53.48%, up 42.0% from a year prior.
  • Gross Margin was 53.22% for Q4 2025 at Ekso Bionics Holdings, down from 60.3% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 64.66% in Q1 2021 to a low of 39.82% in Q2 2025.
  • A 5-year average of 52.32% and a median of 53.22% in 2025 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: surged 2127bps in 2021, then crashed -1756bps in 2022.
  • Ekso Bionics Holdings' Gross Margin stood at 59.27% in 2021, then decreased by -20bps to 47.25% in 2022, then grew by 3bps to 48.88% in 2023, then rose by 9bps to 53.32% in 2024, then decreased by 0bps to 53.22% in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Gross Margin are 53.22% (Q4 2025), 60.3% (Q3 2025), and 39.82% (Q2 2025).